Multiple myeloma will strike over 20,000 people in the United States each year, the Leukemia and Lymphatic Society reported in 2010. Multiple myeloma, a type of blood cell cancer, develops in plasma cells, a type of white blood cell. Plasma cells, normally found in the bone marrow, make antibodies and also produce osteoclast activating factor, which helps bone maintenance by breaking down old bone. When abnormal amounts of antibodies are produced, abnormal proteins appear in the urine and blood. In the urine, these proteins are called...
Multiple myeloma is a rare form of cancer that affects plasma cells, a type of cell found in bone marrow that produces antibodies. According to U.K. National Health Service's website, NHS Choices, multiple myeloma accounts for ...
Multiple myeloma is a type of cancer affecting plasma cells in your body. Plasma cells are found in your body's bone marrow, and when these cells become cancerous, tumors form. Multiple myeloma can lead to a number of problems ...
They include cells called the natural killer cells, macrophages, monocytes, basophils, eosinophils, neutrophils, the T lymphocytes and the B lymphocytes. When the B lymphocytes mature, they become the plasma cells that produce ...
Multiple myeloma is an uncommon cancer attacking the plasma cells, a form of white blood cells, present in bone marrow. Plasma cells make proteins called antibodies that help you battle infections. Many people know the plant tu...
Multiple myeloma is a cancer of plasma cells involving primarily the bone marrow, which releases a distinctive protein into the blood used for diagnosis. The disease usually occurs in older adults, with approximately 16,000 new...
Although uncommon, multiple myeloma is the most common primary bone cancer, according to the American Academy of Orthopaedic Surgeons. This cancer can cause problems with bone breakdown and bone formation, as well as cause dist...
Multiple myeloma is a cancer of the cells in your blood. While it is typically treated with chemotherapy, radiation and stem cell transplantation, exercise may prove to be beneficial when used in conjunction with traditional tr...
Multiple myeloma, cancer of the bone marrow, is the second most common blood cancer after non-Hodgkin's lymphoma, according to the Multiple Myeloma Research Foundation. Approximately 75 percent of those diagnosed are over age ...
Multiple myeloma and myeloid leukemia have much in common. The names are similar, because they are both cancers that start in the bone marrow. Many of the symptoms are similar, and even some of the same drugs are used to trea...
The appendicular skeleton is composed of 126 bones: 64 in the upper limbs and shoulders and 62 in the lower limbs and pelvis. Disorders of the appendicular skeletal system affect the shoulders, arms, elbows, hands, fingers, pel...
Multiple myeloma, a cancer of the bone marrow that causes certain cells to grow out of control and break down bone, is the most common type of bone cancer, according to the University of Maryland Medical Center. The word 'stage...
According to the American Academy of Orthopedic Surgeons (AAOS), multiple myeloma is the most common primary bone cancer, which occurs in four out of every 100,000 people in the United States each year. No known risk factors ar...
The American Cancer Society estimates that 20,580 new cases of multiple myeloma were diagnosed in 2009--about 11,680 in males and 8,900 in females--and that 10,580 Americans died from the disease. Two systems are used to class...
Infections are now the leading cause of death in people with multiple myeloma. Advances in treatment have extended survival; however, certain myeloma therapies weaken patients' immune systems. For these reasons, the spectrum of...
Multiple myeloma is a cancer of the plasma cells in bone marrow. Certain chemicals are suspected as a cause, although the risk remains ill defined. Because multiple myeloma is rare, if a study is not large enough, it may lack t...
Revlimid, manufactured by Celgene, is a derivative of of thalidomide that has extended survival in patients with relapsed multiple myeloma. Some oncologists use it in newly diagnosed patients as well reports the International M...
Multiple myeloma is a rare cancer, affecting about 20,000 Americans each year. Although the exact causes remain unclear, several risk factors have been identified. Established risk factors include older age and male gender, bla...
Lenalidomide, an immunomodulating agent with the brand name Revlimid, is a new therapy for multiple myeloma. It is most often used with chemotherapy for patients who have relapsed after initial treatment. Although it is chemica...
In multiple myeloma, defective plasma cells divide uncontrollably in the bone marrow, crowding out normal disease-fighting cells. This leads to a weakened immune system and damage in the bones and kidneys. Revlimid, which is ma...
There are a variety of treatment options available for multiple myeloma, including novel therapies, stem cell transplantation, and unique combinations of drugs. The side effects of these therapies vary among individuals and dep...
Multiple myeloma is a cancer in the bone marrow of the plasma cells--white blood cells that normally fight infection. The disease causes excessive production of these cells, leading to several complications. The complications v...
Multiple myeloma is a cancer of the plasma cells--white blood cells that are located in the bone marrow. The term multiple myeloma is used because the cancer occurs at more than one site in the bones. There are several variants...
The prognosis for multiple myeloma varies widely, with survival ranging from less than one year in people with aggressive disease to more than 10 years in those with slowly progressing cancer. The American Cancer Society report...
Multiple myeloma is a cancer of the plasma cells, a type of white blood cell that plays an important role in the immune system. Normally, plasma cells help fight infection. They collect in the bone marrow,--the spongy, soft cen...
Multiple myeloma is the second most common blood cancer in the United States, striking more than 20,000 individuals each year. The incidence is higher in men and increases with advanced age. Although the causes are unclear, cer...
Multiple myeloma---cancer that arises in the plasma cells of the bone marrow---is a relatively rare malignancy. Representing 1 percent of cancers in Caucasians and 2 percent in African-Americans, it strikes more than 20,000 ind...
Multiple myeloma is a tumor of your plasma cells, the white blood cells that make antibodies. The tumor starts in your bone marrow, where blood cells are formed, then spreads out and destroys your bone. According to Charles Lin...
A diagnosis of multiple myeloma is frightening to most Americans. This plasma cell cancer strikes at any age but is most common in the elderly. Developing a strategy for your healthcare will empower you and allow you to find th...
Multiple myeloma is considered to be a hematological cancer. This means that it originates in the blood system. Myeloma cells are abnormal plasma cells that develop instead of the normal plasma cells. These cells do not die as ...
Multiple myeloma is a type of cancer that affects the plasma cells found in the blood. These cells are formed in the bone marrow. As the disease process continues, the patient becomes at-risk for several complications. Most of ...
Merck Manuals, an online medical library, reports that multiple myeloma is a form of cancer in which plasma cells become cancerous. Plasma cells are a relatively rare type of blood cell, making up less than 1 percent of total b...
The National Cancer Institute describes multiple myeloma as a cancer that originates in a type of blood cell called a plasma cell. Plasma cells circulate throughout the body and produce antibodies that help rid the body of infe...
The National Cancer Institute reports that multiple myeloma is diagnosed in approximately 20,000 people each year. Multiple myeloma is a type of cancer that begins in a type of white blood cell called a plasma cell. According t...
Multiple myeloma is a cancer of the plasma cells found in bone marrow. The cancerous cells multiply so much that they crowd out normal healthy blood cells and weaken the bones. Once multiple myeloma is diagnosed, the cancer is ...
The plasma cells make antibodies to fight off the attacking organism. According to the National Cancer Institute (NCI), multiple myeloma is a form of cancer that originates in the plasma cells. Appropriate drug therapy enables ...
According to the Merck Manual, a compilation of medical information for medical professionals, plasma cells are derived from B lymphocytes, another type of immune cell that protects the body. Sometimes, the plasma cells can mul...
Multiple myeloma is a type of cancer that affects the plasma cells (a type of white blood cell) in bone marrow. Normal plasma cells make antibodies to fight off infection; however, in those with multiple myeloma, plasma cells f...
These cells are white blood cells that produce antibodies to help you fight disease. For reasons not yet understood, these cells can become cancerous and multiply out of control. When this happens you can develop multiple myelo...
Multiple myeloma, a cancer of the blood cells, specifically affects plasma cells, which are a type of white blood cell the body produces to fight infection. Plasma cells collect in the bone marrow. In multiple myeloma they gro...
